
AI-DoLPHIN: Multi-omics platform for next-gen probiotics/therapeutics for NCDs
The invention
- Name of invention
- AI-DoLPHIN: Multi-omics platform for next-gen probiotics/therapeutics for NCDs
- AI-DoLPHIN : Plateforme multi-omiques pour probiotiques/thérapeutiques de nouvelle génération pour maladies non transmissibles
Invention description
- Description
- An AI-driven platform (DoLPHIN) developed to analyze multi-omics data from a huge mother-baby cohort, with over 130,000 samples from 2,000+ families, aiming to create next-generation probiotics and live biotherapeutics to combat NCDs.
INVENTORS
The Chinese University of Hong Kong / Prof. Lin ZHANG inventor 3700782915_3048
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.